GlassScriptPhysician profile
Ingrid A Prosser
NPI 1245203652
$1,064.83
in general payments reported to CMS, 2019-2025
23 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $161 · 2021: $133 · 2022: $87.52 · 2023: $66.68 · 2024: $134 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.54 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $114.39 | 2019-2025 | |
| Abbvie INC. | $113.35 | 2020-2022 | |
| Coopersurgical, INC. | $89.63 | 2019-2025 | Paragard T 380a |
| Astellas Pharma US INC | $87.72 | 2019-2025 | Veozah |
| Amag Pharmaceuticals, INC. | $68.66 | 2019-2020 | |
| Conmed Corporation | $66.67 | 2019 | |
| Therapeuticsmd, INC. | $65.35 | 2019-2021 | |
| Myovant Sciences INC. | $65.29 | 2021-2022 | |
| Allergan, INC. | $61.71 | 2019-2021 | |
| Avion Pharmaceuticals | $48.29 | 2019 | |
| Daiichi Sankyo INC. | $44.65 | 2024 | Injectafer |
| Mayne Pharma Commercial LLC | $37.88 | 2021-2025 | |
| Organon LLC | $35.60 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $27.70 | 2020-2025 | |
| Duchesnay USA Incorporated | $22.84 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.80 | 2019 | |
| Hologic Sales and Service, LLC | $17.36 | 2022 | |
| Sumitomo Pharma America, INC. | $16.21 | 2023 | Myfembree |
| Intuitive Surgical, INC. | $15.91 | 2019 | |
| Millicent US INC | $13.35 | 2024 | |
| Exeltis, USA INC. | $13.33 | 2024 | Slynd |
| Amgen INC. | $11.41 | 2021 | |
| Meditrina | $9.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Prosser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.